Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced a reduction in both its issued share capital and registered capital following the cancellation of 1,072,246 Restricted Shares. The company’s total issued share capital has decreased, and amendments to the Articles of Association have been made to reflect the updated capital structure. These changes are part of the resolutions passed by shareholders and are in compliance with relevant PRC laws and regulations.
For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.
